Pharma feed

N
Novartis AG
FirstWord Pharma· 06 Dec 2019

FDA approves first generic versions of Novartis' MS drug Gilenya

The FDA said Thursday that it has approved three marketing applications from Sun Pharmaceutical, Biocon and HEC Pharm for the first generics of Novartis' Gilenya (fingolimod) to treat relapsing forms of multiple sclerosis (MS) in adults.

  • Novartis AG
  • Biocon Ltd
  • Sun Pharmaceutical Industries
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Payable
Seeking Alpha· 06 Dec 2019

Bristol-Myers Squibb declares $0.45 dividend

Bristol-Myers Squibb (NYSE:BMY) declares $0.45/share quarterly dividend, 9.8% increase from prior dividend of $0.41. Forward yield 3.02% Payable Feb. 3; for shareholders of record Jan. 3; ex-div Jan. 2.

  • Payable
  • Bristol-Myers Squibb Co
  • Financial and Business Performance
  • News Articles
  • News and Other Websites
N
Novartis AG
Seeking Alpha· 06 Dec 2019

FDA OKs generic versions of Novartis' Gilenya

The FDA approves generic versions of Novartis' (NVS +0.2% ) MS med Gilenya (fingolimod) made by HEC Pharm Co., Ltd., Biocon Limited and Sun Pharmaceutical Industries Limited.

  • Novartis AG
  • OKS Group
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Eli Lilly and Co
MedCity News· 06 Dec 2019

Lilly moves Loxo Oncology executives into new cancer R&D organization

A Midwestern drugmaker is creating a new internal oncology research and development group as part of its integration of a biotech company it acquired earlier this year. Indianapolis-based Eli Lilly & Co. said it would create a new organization within the company, Loxo Oncology at Lilly.

  • Eli Lilly and Co
  • M&A Activities
  • News Articles
  • News and Other Websites
Singtel Optus Pty Limited
Which-50· 06 Dec 2019

Optus names Kelly Bayer Rosmarin as CEO

Kelly Bayer Rosmarin is the new CEO of Optus, replacing Alan Lew, who will move to the management team of Optus parent Singtel after five years at the helm of the Australian telco. Bayer Rosmarin has been Optus deputy CEO since joining from the Commonwealth Bank in March after missing out on the bank’s CEO opening.

  • Singtel Optus Pty Limited
  • Bayer AG
  • Management Changes
  • News Articles
  • Company Websites
  • Teva Pharmaceutical Industries Ltd
  • Regulatory and Legal
  • Social Updates
  • Twitter
  • Amgen, Inc.
  • Events
  • Social Updates
  • Twitter
N
Pfizer Inc.
Globe Newswire· 06 Dec 2019

Continued strong Cresemba® (isavuconazole) sales trigger second sales milestone this year from Pfizer to Basilea of USD 7 million

Basel, Switzerland, December 06, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that sales of the antifungal Cresemba® (isavuconazole) by Pfizer in Europe and Israel exceeded the threshold triggering a sales milestone payment to Basilea of USD 7 million.

  • Pfizer Inc.
  • Procurement and Sales
  • Press Releases
  • Press Release Agencies
N
DePuy Synthes Inc
News-Medical.Net· 06 Dec 2019

DePuy Synthes launches the SYMPHONY Occipito-Cervico-Thoracic System

The Johnson & Johnson Medical Devices Companies today announced that DePuy Synthes has launched the SYMPHONY Occipito-Cervico-Thoracic (OCT) System, expanding its offering for the surgical treatment of conditions in the neck and upper back. The SYMPHONY System includes a differentiated offering of instruments and implants designed for stabilization of the spine in patients undergoing Posterior Cervical Fusion surgery.

  • DePuy Synthes Inc
  • Johnson & Johnson
  • Synthes Inc
  • New Offerings
  • News Articles
  • News and Other Websites
N
Bayer AG
Agri Marketing· 06 Dec 2019

Bayer To Close Facility In Pittsburgh Area, Formerly Known As Mobay

BAYER TO CLOSE FACILITY IN PITTSBURGH AREA, FORMERLY KNOWN AS MOBAY Pittsburgh Post-Gazette reports: Covestro plans to buy a prominent site it occupies along the Parkway West that for 60 years was the North American headquarters of German drug giant Bayer.

  • Bayer AG
  • Cost Cutting
  • News Articles
  • News and Other Websites
N
Bayer AG
The Business Journals· 06 Dec 2019

Bayer site head in Berkeley jumps to Peninsula cancer drug developer

Judy Chou will go from a multinational company that made everything from aspirin to hemophilia A treatments to a smaller company with multiple drugs in clinical trials.

  • Bayer AG
  • Clinical Trials
  • News Articles
  • News and Other Websites
N
Inflectra Corporation
Bigmoleculewatch· 06 Dec 2019

FDA Approves Amgen’s AVSOLA (infliximab-axxq)

Today, the FDA approved Amgen’s AVSOLA (infliximab-axxq), a biosimilar to Janssen’s REMICADE. AVSOLA has the same approved indications label as its reference product.

  • Inflectra Corporation
  • Amgen, Inc.
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Johnson & Johnson
The Business Journals· 06 Dec 2019

Here's why Oregon rejected Johnson & Johnson's pelvic mesh settlement offer

A DOJ lawyer's email sheds light on why the DOJ found the proposal to be inadequate.

  • Johnson & Johnson
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
Amgen, Inc.
Amgen· 06 Dec 2019

FDA Approves AVSOLA™ (infliximab-axxq), a Biosimilar to Remicade®

Do you want to link to this External Site and leave Amgen.com? YOU ARE NOW LEAVING AMGEN'S WEB SITE.

  • Amgen, Inc.
  • Regulatory and Legal
  • Company Websites
N
Amgen, Inc.
San Fernando Valley Business Journal· 06 Dec 2019

Preview: End-of-Decade Deals

Mergers and acquisitions abounded in the Valley during 2019, from Amgen Inc.'s $13.4 billion buy of psoriasis drug Otezla to ServiceTitan's purchase of a water treatment software firm. In addition to M&A, the report features real estate transactions, partnerships and executive hirings and firings.

  • Amgen, Inc.
  • ServiceTitan.
  • Management Changes
  • News Articles
  • News and Other Websites
N
Amgen, Inc.
San Fernando Valley Business Journal· 06 Dec 2019

Amgen's Arthritis Drug Avsola Gets FDA Approval

Amgen Inc. on Friday announced its biosimilar treatment for rheumatoid arthritis was approved by the Food and Drug Administration. The Thousand Oaks biotech’s Avsola is a biosimilar copy of Remicade, Johnson & Johnson’s blockbuster drug that also treats rheumatoid arthritis.

  • Amgen, Inc.
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
U.S. Food and Drug Administration
Nasdaq· 06 Dec 2019

First Generics Of Gilenya Gets Approval

(RTTNews) - The U.S. Food and Drug Administration has approved three generic versions of Novartis' Gilenya capsule for treating relapsing forms of multiple sclerosis. "Approving safe and effective generics so patients have more treatment options continues to be a priority for the FDA," said Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research.

  • U.S. Food and Drug Administration
  • Novartis AG
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Novartis AG
Fdanews· 05 Dec 2019

FDA Approves First Gilenya Generics

Novartis’ blockbuster multiple sclerosis drug Gilenya (fingolimod) may soon face generic competitors in the U.S., following three FDA approvals. Biocon, HEC Pharm and Sun Pharmaceutical all received the agency’s approval for their generic versions of the immunosuppressive drug, which is intended to treat relapsing forms of the chronic, inflammatory autoimmune disease in adult patients.

  • Novartis AG
  • Biocon Ltd
  • Sun Pharmaceutical Industries
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
  • Applied Genomics Inc
  • Amgen, Inc.
  • Keck Graduate Institute
  • Awards and Recognitions
  • Social Updates
  • Twitter
Twitter· 05 Dec 2019

Our team grew to over 600 employees in 2019, and we’re still growing. Discover the latest opportunities to join us in our quest to treat and defeat cancer: https://t.co/UMncDuR4XH.

Culture & Values
“Here I am valued for who I am. There is no need to have a “work Jen” and a “home Jen.” Exelixis values people for who they are and what they contribute.” – Jen, Marketing, Exel...
  • Exelixis Inc
  • Discover
  • Events
  • Social Updates
  • Twitter
  • Hoffmann-La Roche Ltd
  • Events
  • Social Updates
  • Twitter
  • GlaxoSmithKline PLC
  • Computershare
  • AstraZeneca PLC
  • Awards and Recognitions
  • Social Updates
  • Twitter
Novartis AG
Novartis· 05 Dec 2019

Head Tax Reporting and Tax Accounting (80-100%*)

Job Description More than $50bn of net sales, more than $12bn of net income, 155 countries where our products are sold - these are the underlying numbers of Novartis that need to be managed from a tax and accounting perspective! As our Head Tax Reporting and Tax Accounting, you will lead tax accounting within the Novartis Group and provide functional guidance to the FRA Operations teams.

  • Novartis AG
  • Financial and Business Performance
  • Company Websites
N
Johnson & Johnson
MassDevice· 05 Dec 2019

J&J’s Ethicon gets to substitute 20 new claims on surgical stapler patent

Johnson & Johnson (NYSE:JNJ) may file new claims in a surgical stapler patent case brought by Intuitive Surgical (NSDQ:ISRG) against J&J’s Ethicon unit. The original patent was granted in 2015. Ethicon sued Intuitive in Delaware in 2017, alleging that with the EndoWrist stapler Intuitive developed for its da Vinci robot-assisted surgery platform, Intuitive violates seven Ethicon patents covering its Echelon Flex line of endocutters and staplers.

  • Johnson & Johnson
  • Ethicon Inc
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
Best Buy Co Inc
Johnson & Johnson· 05 Dec 2019

Johnson & Johnson Names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors

Our Company New Brunswick, NJ (December 5, 2019) – Johnson & Johnson announced today that Hubert Joly, Executive Chairman of Best Buy Co., Inc, and Mark A. Weinberger, Former EY Global Chairman and CEO, have been appointed to its Board of Directors.

  • Best Buy Co Inc
  • Johnson & Johnson
  • Management Changes
  • Company Websites
1 2 3 4 5